B&G Foods (BGS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
15 May, 2026Executive summary
Completed major portfolio reshaping with divestitures of Green Giant U.S. Frozen, Don Pepino, and Le Sueur U.S., and pending sale of Green Giant Canada, plus acquisition of College Inn and Kitchen Basics broth brands.
Portfolio changes aim to simplify operations, focus on core shelf-stable categories, and improve margins and cash flow.
Q4 2025 net sales declined 2.2% YoY to $539.6M, primarily due to divestitures, while base business net sales rose 0.8%.
Full year 2025 net sales fell 5.4% to $1.829B, with base business net sales down 4.0%.
Net loss for Q4 2025 was $15.2M, a significant improvement from a $222.4M loss in Q4 2024, mainly due to lower impairment charges.
Financial highlights
Q4 2025 net sales: $539.6M (down 2.2% YoY); adjusted EBITDA: $84.7M (15.7% margin); adjusted net income: $22.8M ($0.28/share).
FY 2025 net sales: $1.829B; adjusted EBITDA: $272.2M (14.9% margin); adjusted net income: $41.3M ($0.51/share).
Q4 2025 gross profit margin improved to 22.7% (adjusted: 23.0%) from 21.5% (adjusted: 22.2%) in Q4 2024.
Net cash from operating activities in Q4 2025: $95.4M, up from $80.3M YoY.
Net interest expense decreased 5.0% for the year due to lower debt and interest rates.
Outlook and guidance
FY 2026 guidance: net sales $1.655B–$1.695B, adjusted EBITDA $265M–$275M, adjusted EBITDA margin 16%–16.5%, adjusted EPS $0.55–$0.65.
Guidance reflects one fewer reporting week, recent divestitures, and excludes pending acquisitions and divestitures.
Base business trends expected to improve +0.4% YoY; Q1 2026 off to a strong start with 4% growth in base business net sales through February.
Leverage targeted to fall to near 6.0x by mid-2026, with long-term goal of 4.5x–5.5x.
Guidance does not fully reflect potential impacts of tariffs or retaliatory trade actions.
Latest events from B&G Foods
- Portfolio reshaping led to higher base sales, a net loss, and a 50% dividend cut.BGS
Q1 202613 May 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the 2026 virtual meeting.BGS
Proxy filing3 Apr 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.BGS
Proxy filing3 Apr 2026 - Q2 sales fell 5.3%, goodwill impairment hit results, and guidance was revised lower.BGS
Q2 20242 Feb 2026 - Portfolio reshaping and operational improvements target margin recovery and 2024 growth.BGS
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Q3 2024 sales and EBITDA declined, but net income turned positive; outlook remains cautious.BGS
Q3 202416 Jan 2026 - Portfolio streamlining and cost initiatives aim to boost margins and enable future growth.BGS
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Sequential improvement, strong spices growth, and major impairments shape 2025 outlook.BGS
Q4 202418 Dec 2025 - Shelf registration allows up to $800M in securities for growth, debt, and acquisitions.BGS
Registration Filing16 Dec 2025